When is the MMR vaccine indicated in the management of HIV infection in primary care?

Updated: Apr 09, 2019
  • Author: Jason F Okulicz, MD, FACP, FIDSA; Chief Editor: Michael Stuart Bronze, MD  more...
  • Print


Measles, mumps, and rubella (MMR)

Live vaccine is contraindicated for use in patients with severe immunosuppression (CD4 count < 200 cells/µL). Administer to all nonimmune persons with CD4 counts of 200 cells/µL or more.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!